Plenary session – Pharmaceutical traceability from manufacturer to patient
Standards in humanitarian work - Mr. Tom Woods, Chairman of the Global Steering Committee for Quality Assurance, World Bank, U.S.
Standards in humanitarian work - Dr. Ramy Guirguis, Senior Information Technology Advisor, USAID, U.S.
Early learnings from policy work on implementation of global standards - Mr. Yehulu Denekew, Director General, Food, Medicine, Health Care Administration and Control Authority of Ethiopia (FMHACA)
US FDA Drug Supply Chain Security Act (DSCSA) - Ms. Connie T. Jung, RPh, PhD, Senior Advisor for Policy, Office of Drug Security, Integrity, and Response (ODSIR), Center for Drug Evaluation and Research, Office of Compliance, U.S. Food and Drug Administration
Panel – DSCSA Implementation - Mr. Scott Mooney, Vice President, Distribution Operations, McKesson; Mr. Chris Reed, Lead, Product Serialization and Traceability, Johnson & Johnson, U.S.; Mr. Jeff Denton, Sr. Director, Global Secure Supply Chain, AmerisourceBergen, U.S.; Mr. Thomas McHugh, Sr. Strategist SC Systems, CVS Health, U.S.
European Union Falsified Medicines Directive - Mr. Mike Rose, Vice President, Supply Chain Visibility, Johnson & Johnson, U.S.;
Pharmaceutical traceability in Brazil - Ms. Bianca Zimon Giacomini Ribeiro, Deputy Chief Adviser for International Affairs, National Agency of Sanitary Surveillance (Anvisa), Brazil
Achieving single unit pharmaceutical traceability - Mr. Tjalling van der Schors, Pharm.D., Hospital Pharmacist, President NVZA, Director of Pharmacy, WestfriesGasthuis, Netherlands
Identification of Medicinal Products (IDMP) - Ta-Jen (TJ) Chen, Project Management Officer, FDA/CDER/ Office of Strategic Programs, U.S. Food and Drug Administration